Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Australian Stock Exchange  >  Mayne Pharma Group Limited    MYX   AU000000MYX0

MAYNE PHARMA GROUP LIMITED

(MYX)
  Report
SummaryChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsPress ReleasesOfficial PublicationsSector news
Most relevant news about MAYNE PHARMA GROUP LIMITED
01/06MAYNE PHARMA : Launches Pregnancy Prevention Tablets in US
MT
01/06MAYNE PHARMA : launches Microgestin 24 FE tablets in the US
PU
01/06MAYNE PHARMA : 07/01/2021 Mayne Pharma launches Microgestin® 24 Fe tablets in th..
PU
2020MAYNE PHARMA : Extends Three-Year Bullet Facility
MT
2020MAYNE PHARMA : 18/12/2020 Mayne Pharma successfully extends debt facility
PU
2020MAYNE PHARMA : successfully extends debt facility
PU
2020MAYNE PHARMA : 24/11/2020 2020 AGM Chairman's Address
PU
2020MAYNE PHARMA : 24/11/2020 2020 AGM CEO's Speech
PU
2020MAYNE PHARMA : 09/11/2020 Mayne Pharma Board Renewal
PU
2020MAYNE PHARMA : Board Renewal
PU
2020MAYNE PHARMA : New data on Mayne Pharma's TOLSURA presented at IDWeek 2020
AQ
2020MAYNE PHARMA : 26/10/2020 New data on Mayne Pharma's TOLSURA presented at IDWeek..
PU
2020MAYNE PHARMA : Lapse of rights and AGM Notice of Meeting clarification
PU
2020MAYNE PHARMA : 2020 Annual General Meeting
PU
2020MAYNE PHARMA : 2020 Corporate Governance Statement
PU
2020MAYNE PHARMA : Annual Report to shareholders
PU
2020Mithra Announces FDA update
AQ
2020MAYNE PHARMA : provides update on Women's Health pipeline
AQ
2020MAYNE PHARMA : 06/10/2020 Mayne Pharma provides update on Women's Health pipelin..
PU
2020MAYNE PHARMA : Appoints Chief Financial Officer
AQ
2020MAYNE PHARMA : appoints new CFO
PU
2020MAYNE PHARMA : 29/09/2020 Mayne Pharma Appoints Chief Financial Officer
PU
2020MAYNE PHARMA : Appendix 4E and Statutory Accounts
PU
2020MAYNE PHARMA : 2020 Full Year Media Release
PU
2020MAYNE PHARMA : 2020 Full Year Investor Presentation
PU
2020MAYNE PHARMA : 21/08/2020 Mayne Pharma FY20 Results Media Release
PU
2020MAYNE PHARMA : Announces strategic partnership with novast
AQ
2020MAYNE PHARMA : Announces Expansion of US Production Space
AQ
2020Mithra Announces FDA Filing Acceptance of New Drug Application for Estelle in..
AQ
2020MAYNE PHARMA : Announces FDA Filing Acceptance of New Drug Application for E4/DR..
AQ
2020MAYNE PHARMA : Toni Nesci named head of Mayne Contract Services and New Website ..
AQ
2020MAYNE PHARMA : signs license agreement for contraceptive in Australia
AQ
2020MAYNE PHARMA : submits NDA for E4/DRSP to the FDA
AQ
2020MAYNE PHARMA : Resignation of group chief financial officer and appointment of i..
AQ
2020MAYNE PHARMA : 20/03/2020 Change of CFO and Company Secretary
PU
2020MAYNE PHARMA : 2020 Half Year Media Release
PU
2020MAYNE PHARMA : Half Yearly Report and Accounts
PU
2020MAYNE PHARMA : 2020 Half Year Investor Presentation
PU
2020MAYNE PHARMA : 21/02/2020 Mayne Pharma 2020 Half Year Media Release
PU
2020MAYNE PHARMA GROUP LIMITED : half-yearly earnings release
2019MAYNE PHARMA : Aspires To Specialisation
AQ
2019MAYNE PHARMA : Final Director's Interest Notice
PU
2019MAYNE PHARMA : 22/11/2019 2019 AGM CEO's Speech
PU
2019MAYNE PHARMA : 22/11/2019 2019 AGM Chairman's Address
PU
2019MAYNE PHARMA : 2019 AGM CEO's Speech
PU
2019MAYNE PHARMA : 2019 AGM Chairman's Address
PU
2019MAYNE PHARMA : 23/10/2019 E4/DRSP contraceptive presented at EU gynecology confe..
PU
2019MAYNE PHARMA : E4/DRSP contraceptive presented at EU gynecology conference
PU
2019MAYNE PHARMA : Retirement of Director
PU
2019MAYNE PHARMA : 21/10/2019 Retirement of Director
PU
2019MAYNE PHARMA : 21/10/2019 Notice of Annual General Meeting/Proxy Form
PU
2019MAYNE PHARMA : Change of Director's Interest Notice (x2)
PU
2019MAYNE PHARMA : 2019 Annual Report
PU
2019MAYNE PHARMA : Appendix 4G and Corporate Governance Statement
PU
2019MAYNE PHARMA : MYX signs license agreement for novel oral contraceptive
PU
2019MAYNE PHARMA : 02/10/2019 Mayne Pharma signs 20-year license agreement for novel..
PU
2019MAYNE PHARMA : Lapse of employee options
PU
2019MAYNE PHARMA : Appendix 4E and Full Year Statutory Accounts
PU
2019MAYNE PHARMA : 2019 Full Year Results Media Release
PU
2019MAYNE PHARMA : 2019 Full Year Results Investor Presentation
PU
2019MAYNE PHARMA : 23/08/2019 FY19 Results Media Release
PU
2019MAYNE PHARMA : Lapse of employee options
PU
2019MAYNE PHARMA : market update
PU
2019MAYNE PHARMA : investor presentation to Goldmans conference
PU
2019MAYNE PHARMA : Half Year Accounts
PU
2019MAYNE PHARMA : 2019 Half Year Investor Presentation
PU
2019MAYNE PHARMA : 22/02/2019 HY19 Results Media Release
PU
2019MAYNE PHARMA GROUP LTD : half-yearly earnings release
2019MAYNE PHARMA : announces new indication for Kapanol by TGA
PU
2019MAYNE PHARMA : 19/02/2019 Mayne Pharma Announces New Chronic Breathlessness Indi..
PU
2019MAYNE PHARMA : Lexette (halobetasol) foam now launched in the US
PU
2019MAYNE PHARMA : 13/02/2019 Mayne Pharma Launches Lexette™ (Halobetasol Prop..
PU
2019MAYNE PHARMA : Tolsura (SUBA-itraconazole) capsule now launched in the US
PU
2018MAYNE PHARMA : MYX extends debt facility and adds receivables facility
PU
2018MAYNE PHARMA : 20/12/2018 Mayne Pharma extends debt facility and adds receivable..
PU
1  2  3Next
Upcoming event on MAYNE PHARMA GROUP LIMITED